Skip to Main Content

SAN FRANCISCO — They print DNA, design proteins, and sell pipetting robots — all the traditionally forgotten back-end technology supporting the drug developers that command the spotlight.

But these days, a once-sleepy industry has been reinvented as the booming field of synthetic biology.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED